72 results
A1C and eAG
~
*For Educational Purposes Only*

#Diabetes #T2D #DM2 #Table #PrimaryCare #Endocrinology #BloodGlucose #A1C
#Diabetes #T2D ... #DM2 #Table #PrimaryCare
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
lowered CV events in T2DM ... lowered CV events in T2DM ... events in CKD + T2DM ... with or without T2DM ... visualabstract #table
Adverse Effects of Antipsychotic Medications - Comparison Table

First Generation: chlopromazine, haloperidol, fluphenazine 
Second Generation: aripirazole, asenapine,
Medications - Comparison Table ... Dyslipidemia, Weight Gain/T2DM ... Profiles #Comparison #Table
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
#SideEffects #Table ... DecisionAid #Orals #DM2
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
Summary table of ... #pharmacology #dm2
Burn Wound Assessment - Classification Table #Diagnosis #Clinical #Burn #Classification #Table #Epidermal #Superficial
Wound Assessment - Classification ... Table #Diagnosis ... Clinical #Burn #Classification ... #Table #Epidermal
Severity of Aortic Stenosis in Adults 
Current ACC/AHA guidelines recommend cut-off values for Doppler-echocardiographic measurements of
area (AVA) <1.0 cm2 ... surface area <0.6 cm2 ... /m2, mean gradient ... >50 mmHg (2) (Table ... AorticStenosis #Classification
Antiarrhythmic Medication Table

#Antiarrhythmic #Medications #Table #Classification #Classes #Cardiology #Pharmacology
Antiarrhythmic Medication Table ... #Medications #Table ... #Classification
Classification of the Cardiomyopathies - Dilated, Hypertrophic, and Restrictive

#Cardiomyopathy #Classification #Table #Comparison #Cardiology #Diagnosis
Classification of ... Cardiomyopathy #Classification ... #Table #Comparison
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Medications Summary Table ... #medications #table ... endocrinology #dm2